1. Introduction 1.1 Market Definition 2. Research Methodology 3. Executive Summary 4. Key Inferences 5. Market Overview 5.1 Current Market Scenario 5.2 Porter's Five Forces Analysis 5.2.1 Bargaining Power of Suppliers 5.2.2 Bargaining Power of Consumers 5.2.3 Threat of New Entrants 5.2.4 Threat of Substitute Product and Services 5.2.5 Competitive Rivalry within the Industry 6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 6.1 Market Drivers 6.1.1 Presence of a huge Diabetic Population 6.1.2 Growing Awareness Regarding Diabetes Care 6.1.3 Innovative Product Development 6.2 Market Restraints 6.2.1 Lack of Proper Reimbursement Policies 6.2.2 High Cost of Diabetes Care Devices 6.3 Opportunities 6.4 Key Challenges 7. Market Segmentation 7.1 By Product 7.1.1 Glucose Monitoring Devices 7.1.1.1 Continuous Glucose Monitoring Device 7.1.1.2 Lancets 7.1.1.3 Self-monitoring Blood Glucose Meters 7.1.1.4 Testing Strips 7.1.2 Insulin Delivery Devices 7.1.2.1 Insulin Jet Injectors 7.1.2.2 Insulin Syringes 7.1.2.3 Insulin Pumps 7.1.2.4 Insulin Pens 7.2 By Geography 7.2.1 Asia-Pacific 7.2.1.1 China 7.2.1.2 Japan 7.2.1.3 India 7.2.1.4 Australia & New Zealand 7.2.1.5 South Korea 7.2.1.6 Rest of Asia-Pacific 8. Competitive Landscape 8.1 Mergers and Acquisition Analysis 8.2 Agreements, Collaborations, and Partnerships 8.3 New Products Launches 9. Key Players 9.1 Abbott 9.2 Acon Laboratories 9.3 Bayer AG 9.4 Becton, Dickinson and Company 9.5 Eli Lilly & Co. 9.6 F. Hoffmann-La Roche Ltd 9.7 Johnson and Johnson 9.8 Medtronic PLC 9.9 Novo Nordisk A/S 9.10 Sanofi 9.11 List Not Exhaustive 10. Future of the Market

Abbott, Acon Laboratories, Inc., Bayer Ag, Becton, Dickinson And Company, Eli Lilly & Co., F. Hoffmann-La Roche Ltd, Johnson And Johnson, Medtronic Plc, Novo Nordisk A/S, Sanofi